Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventable stroke and stroke prevention.

G J Hankey1

  • 1Department of Neurology, Royal Perth Hospital, Perth, Australia. gjhankey@cyllene.uwa.edu.au

Journal of Thrombosis and Haemostasis : JTH
|August 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic evaluation of the Very Early Rehabilitation in SpEech (VERSE) intervention.

Topics in stroke rehabilitation·2023
Same author

Hearing Impairment and Incident Frailty in Later Life: The Health in Men Study (HIMS).

The journal of nutrition, health & aging·2023
Same author

Beyond Stroke Prevention in Atrial Fibrillation: Exploring Further Unmet Needs with Rivaroxaban.

Thrombosis and haemostasis·2018
Same author

Risk of prevalent and incident dementia associated with insulin-like growth factor and insulin-like growth factor-binding protein 3.

Molecular psychiatry·2017
Same author

Depression as a modifiable factor to decrease the risk of dementia.

Translational psychiatry·2017
Same author

Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.

European journal of neurology·2016
Same journal

The Natural Mutation Arg221aTrp in Human α-Thrombin Abrogates Physiological Na<sup>+</sup> Binding and Preferentially Hinders the Protease Anticoagulant Functions.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

A historical review of the biological, semantic and clinical aspects of aspirin resistance.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Association between Thrombus Neutrophil Extracellular Traps Content and Ischemic Stroke Recurrence.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Peptide-Mediated Inhibition of Surface-Initiated Thrombogenesis.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Physiological Anticoagulant Deficiencies: Pathogenesis, Diagnosis, and Clinical Implications.

Journal of thrombosis and haemostasis : JTH·2026
See all related articles

Stroke prevention involves community-wide risk factor reduction and targeted therapies for high-risk individuals. Effective treatments include blood pressure and cholesterol control, antithrombotic medications, and carotid revascularization.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Stroke is a leading global cause of death and disability.
  • Key stroke causes include atherothromboembolism and cardiogenic embolism.
  • Modifiable risk factors such as hypertension, hyperlipidemia, smoking, diabetes, atrial fibrillation, and ischemic heart disease contribute significantly to stroke incidence.

Purpose of the Study:

  • To outline strategies for stroke prevention and treatment.
  • To differentiate between population-wide and high-risk approaches to stroke prevention.
  • To review evidence-based medical therapies for reducing stroke risk.

Main Methods:

  • Review of existing literature and randomized controlled trials.
  • Analysis of population-based and individual-focused prevention strategies.

Related Experiment Videos

  • Evaluation of pharmacological and interventional treatments for stroke risk reduction.

    • Main Results:

    • Effective stroke prevention strategies include population-level interventions and targeted management of high-risk individuals.
    • Evidence supports controlling risk factors like blood pressure and cholesterol.
    • Antithrombotic therapies (antiplatelet and anticoagulant) and carotid revascularization are proven interventions for specific patient groups.

    Conclusions:

    • A dual approach combining public health initiatives and personalized medical care is crucial for reducing stroke burden.
    • Optimal medical management of risk factors and appropriate use of antithrombotic therapy significantly lower stroke incidence and improve outcomes.
    • Carotid revascularization offers a valuable treatment option for selected patients with severe carotid stenosis.